ZEUS ARCO: Open Payments
NPI 1386134278 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,646 in 193 payments from 19 companies in 2025. Trend: 2023 $3,333 · 2024 $2,813 · 2025 $3,646
Food & beverage: $3,646
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $578 |
| ABBVIE INC. | 29 | $454 |
| Amgen Inc. | 31 | $338 |
| Corcept Therapeutics | 12 | $288 |
| Novo Nordisk Inc | 14 | $254 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $237 |
| Lilly USA, LLC | 10 | $211 |
| Merck Sharp & Dohme LLC | 9 | $204 |
| Novartis Pharmaceuticals Corporation | 14 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $192 |
Products named: Korlym, OTEZLA, Kerendia, BREZTRI, AIRSUPRA, LEQVIO, CAPLYTA, VRAYLAR.
Industry payments across TX — which companies pay providers there.
